Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
An update from Belluscura PLC ( (GB:BELL) ) is now available.
Belluscura PLC announced it has successfully raised approximately £4.0 million through the placement of 199,151,375 new ordinary shares aimed at existing and new institutional investors. This strategic move, facilitated by joint brokers Dowgate and Allenby, signifies a significant step in Belluscura’s capital management strategy, potentially enhancing their market presence and capacity for innovation in medical device technology.
More about Belluscura PLC
Belluscura PLC is a UK-based medical device company specializing in the development of oxygen enrichment technology, serving a wide range of industries and therapeutic applications.
YTD Price Performance: -29.73%
Average Trading Volume: 149,443
Technical Sentiment Consensus Rating: Buy
Current Market Cap: £10.95M
Find detailed analytics on BELL stock on TipRanks’ Stock Analysis page.
